Conformis to Host Fourth Quarter and Fiscal Year 2019 Financial Results Webcast on March 2, 2020
February 20 2020 - 4:52PM
Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a
webcast and conference call on Monday, March 2, 2020, at 4:30 p.m.
Eastern Time to discuss its financial results for the fourth
quarter and fiscal year ended December 31, 2019. The webcast
will be live at:
https://edge.media-server.com/mmc/p/4n3s4un4.
To attend by telephone, please use the
information below for dial-in access. When prompted on
dial-in, please utilize conference ID: 1256797.
Participant conference numbers: (877)
809-6331 (U.S./Canada) and (615) 247-0224 (International).
Please dial in at least 10 minutes before the
call to ensure timely participation.
The webcast will be hosted by Mark Augusti,
President and Chief Executive Officer; Bob Howe, Chief Financial
Officer; and Fred Driscoll, former Interim Chief Financial Officer
and now consultant. Please visit the Investor Relations
website at ir.conformis.com on March 2, 2020 to view the earnings
release prior to the webcast and conference call.
The online archive of the webcast will be
available on the company’s website at ir.conformis.com for 30
days.
About Conformis, Inc.
Conformis is a medical technology company
that uses its proprietary iFit Image-to-Implant technology platform
to develop, manufacture, and sell joint replacement implants and
instruments that are individually sized and shaped, which we refer
to as personalized, individualized, or sometimes as customized, to
fit each patient’s unique anatomy. Conformis offers a broad
line of sterile, personalized knee and hip implants and single-use
instruments delivered to hospitals. In clinical
studies, the Conformis iTotal CR knee replacement system
demonstrated superior clinical outcomes, including better function
and greater patient satisfaction, compared to traditional,
off-the-shelf implants. Conformis owns or exclusively
in-licenses issued patents and pending patent applications that
cover personalized implants and patient-specific instrumentation
for all major joints.
For more information, visit www.conformis.com.
To receive future releases in e-mail alerts, sign up at
http://ir.conformis.com/.
Contact
Investor Contact:
Investor Relations
ir@conformis.com
(781) 374-5598
Conformis (NASDAQ:CFMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Conformis (NASDAQ:CFMS)
Historical Stock Chart
From Apr 2023 to Apr 2024